Delivery Order SPE2DB20D3101-SPE2DB24FRUU3

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg dose syringes. The contract has a ceiling value of $49,439.68 and a period of performance through May 6, 2025. It is a firm-fixed-price contract, indicating a pre-determined unit price for the medication. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 milligram dose syringes. The contract has a ceiling value of $9,389.20 and runs through August 21, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cosentyx (secukinumab) 300 mg/2 mL prefilled pens, a medication used to treat certain autoimmune conditions. The contract has a ceiling value of $1,574.56 and a period of performance through April 23, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (Secukinumab) 300 mg/2 mL injectable medication. The contract has a ceiling value of $3,910.45 and a period of performance through July 1, 2025. It is a Firm Fixed Price contract, indicating a set price for the delivery of the specified medication. The contract is not set-aside and is open to all qualified vendors....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab) 300 mg dosage pens, a specialty medication used for various medical conditions. The contract has a ceiling value of $21,495.87 and runs through June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a large pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300mg dose-2 pen injectors. The $10,653.65 firm fixed-price contract does not have a set-aside designation and has an ultimate completion date of August 1, 2024. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, AmerisourceBergen holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Cosentyx (Secukinumab) 300 mg pens, a specialty medication used to treat various autoimmune conditions. The contract has a ceiling value of $7,872.80 and runs through April 1, 2025. The contract is a firm fixed-price, delivery order contract and was not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Cosentyx 300mg dose-2pen prefilled syringes. The contract has a ceiling value of $12,131.83 and a completion date of July 25, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (Secukinumab) 300mg dose injector pens, a specialty biologic medication used to treat certain autoimmune conditions. The fixed-price contract has a ceiling value of $9,165.29 and a completion date of August 6, 2024. This order is likely part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx 300 mg dose-2 syringes. The contract has a ceiling value of $16,186.15 and a completion date of April 2, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRUU3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300mg dose injectable pens. The contract has a ceiling value of $40,454.43 and an ultimate completion date of September 16, 2024. It is a firm-fixed-price contract, which indicates the government has agreed to pay a predetermined amount for the product regardless of the contractor's actual costs. The contract does not have a set-aside designation, meaning it was not limited to a particular business category. As a significant supplier of pharmaceutical and medical products to the U.S. federal government, AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by agencies such as the DLA and Department of Justice, providing a wide range of critical care materials and prescription drugs to support military, veterans, and other federal healthcare programs.

Generated 12/13/24, 9:31 AM